Colitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Colitis stocks.

Colitis Stocks Recent News

Date Stock Title
May 17 JAGX Jaguar Health announces 1-for-60 reverse stock split
May 17 JAGX Jaguar Health, Inc. Announces Reverse Stock Split
May 17 BHC Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
May 17 HCM HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
May 16 GLPG Galapagos creates new subscription right plans
May 15 GLPG Galapagos, BCA to collaborate on CAR-T cell therapy production
May 15 GLPG Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
May 15 BHC RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich
May 15 BHC Bausch Health Announces 2024 Annual Meeting of Shareholder Results
May 15 JAGX Jaguar Health Inc (JAGX) Q1 2024 Earnings Call Transcript Highlights: Strategic Expansions and ...
May 14 BHC Bausch issues update on Xifaxan patent dispute with Norwich
May 14 BHC Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters
May 14 BHC Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
May 14 PTGX Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
May 14 JAGX Jaguar Health, Inc. (JAGX) Q1 2024 Earnings Call Transcript
May 14 JAGX Jaguar Health GAAP EPS of -$0.06 misses by $0.03, revenue of $2.35M misses by $0.61M
May 14 JAGX Jaguar Health Reports First Quarter 2024 Financial Results
May 14 LXRX New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
May 14 HCM HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui
May 14 HCM HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
Colitis

Colitis is an inflammation of the colon. Colitis may be acute and self-limited or long-term. It broadly fits into the category of digestive diseases.
In a medical context, the label colitis (without qualification) is used if:

The cause of the inflammation in the colon is undetermined; for example, colitis may be applied to Crohn's disease at a time when the diagnosis is unknown, or
The context is clear; for example, an individual with ulcerative colitis is talking about their disease with a physician who knows the diagnosis.

Browse All Tags